Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Tur

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2019
Clinical relevance of cortical network dynamics in early primary progressive MSCarmen Tur, Baris Kanber, Arman Eshaghi, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 2, 2020
Sodium in the Relapsing-Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue AnisotropyBhavana S Solanky, Ferran Prados, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2017
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosisNiamh Cawley, Carmen Tur, Ferran Prados, et al.
Neurology|March 9, 2018
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSDRosa Cortese, Lise Magnollay, Carmen Tur, et al.
Magnetic Resonance in Medicine|March 1, 2020
Translating pH-sensitive PROgressive saturation for QUantifying Exchange rates using Saturation Times (PRO-QUEST) MRI to a 3T clinical scannerMina Kim, Aaron Kujawa, Marco Battiston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 2018
Structural network disruption markers explain disability in multiple sclerosisThalis Charalambous, Carmen Tur, Ferran Prados, et al.
Scientific Reports|February 29, 2020
Disrupted principal network organisation in multiple sclerosis relates to disabilityThalis Charalambous, Jonathan D Clayden, Elizabeth Powell, et al.
Archives of Neurology|November 16, 2011
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-upCarmen Tur, Xavier Montalban, Mar Tintoré, et al.
Brain : a Journal of Neurology|February 26, 2016
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritisCarmen Tur, Olivia Goodkin, Daniel R Altmann, et al.
Neuroimage. Clinical|May 22, 2022
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosisAlberto Calvi, Carmen Tur, Declan Chard, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2019
Clinical relevance of cortical network dynamics in early primary progressive MSCarmen Tur, Baris Kanber, Arman Eshaghi, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 2, 2020
Sodium in the Relapsing-Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue AnisotropyBhavana S Solanky, Ferran Prados, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2017
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosisNiamh Cawley, Carmen Tur, Ferran Prados, et al.
Neurology|March 9, 2018
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSDRosa Cortese, Lise Magnollay, Carmen Tur, et al.
Magnetic Resonance in Medicine|March 1, 2020
Translating pH-sensitive PROgressive saturation for QUantifying Exchange rates using Saturation Times (PRO-QUEST) MRI to a 3T clinical scannerMina Kim, Aaron Kujawa, Marco Battiston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 2018
Structural network disruption markers explain disability in multiple sclerosisThalis Charalambous, Carmen Tur, Ferran Prados, et al.
Scientific Reports|February 29, 2020
Disrupted principal network organisation in multiple sclerosis relates to disabilityThalis Charalambous, Jonathan D Clayden, Elizabeth Powell, et al.
Archives of Neurology|November 16, 2011
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-upCarmen Tur, Xavier Montalban, Mar Tintoré, et al.
Brain : a Journal of Neurology|February 26, 2016
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritisCarmen Tur, Olivia Goodkin, Daniel R Altmann, et al.
Neuroimage. Clinical|May 22, 2022
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosisAlberto Calvi, Carmen Tur, Declan Chard, et al.
Pageof 15